1902 ET - Health insurer Tricare's temporary suspension of payments to Zynex could last as long as a year, Chief Financial Officer Anna Lucsok told investors during an earnings call Tuesday. Tricare makes up about a quarter of Zynex's revenue, and the pause caused it to lower revenue guidance for the year. Zynex said it is unclear what specifically triggered Tricare's pause. Zynex is still in Tricare's network and if Tricare starts paying again, it would be responsible for paying all claims that it has processed during its halt, Lucsok said. Zynex shares fall 19%, to $5.65, after market close. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
March 11, 2025 19:03 ET (23:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。